Author:
KOBAYASHI Shinichi,MURRAY Stephen,WATSON David,SESARDIC Dorothea,BOOBIS Alan R.,DAVIES Donald S.,YASUHARA Hajime
Publisher
The Showa University Society
Reference13 articles.
1. 1) Kobayashi S, Tanaka E, Oguchi K, Yoshida T, Kuroiwa Y and Yasuhara H: A method for estimation of hepatic drug-metabolizing capacity: Determination of concentration of trimethadione and its metabolite in human serum. J Pharmacobiodyn, 7: 329-335 (1984)
2. 2) Tanaka E, Ishikawa A, Ono A, Okamura T, Kobayashi S, Yasuhara H and Misawa S: Trimethadione tolerance test for evaluation of functional reserve of the liver in patients with liver cirrhosis and esophageal varices. J Pharmacobiodyn, 9: 297-302 (1986)
3. 3) Tanaka E, Ishikawa A, Ono A, Okamura T and Misawa S: Age-related changes in trimethadione oxidizing capacity. Br J Clin Pharmacol, 23: 355-357 (1987)
4. 4) Idle JR and Smith LR: The debrisoquine gene: A gene of multiple consequence. In: Proceeding of the Second World Conference on Clinical Pharmacology and Therapeutics, Lemberger L and Reidenberg MM (Eds) , American Society for Pharmacology and Experimental Therapeutics, Washington, DC, pp148-164 (1984)
5. 5) Nakamura K, Goto F, Ray WA, McAllister CB, Jacqz E, Wilkinson GR and Branch RA: Interethnic differences in genetic polymorphism of debrisoquine and mephenytoin hydroxylation between Japanese and Caucasian populations. Clin Pharmacol Ther, 38: 402-408 (1985)